Menu

Activity Detail

Attention Pharmacists and Pharmacy Techs: Click to access CPE Monitor and latest CE information More Information

Featured Activity

This activity will cover key topics of interest to stakeholders who set practice policy and will be called upon to evaluate and make decisions on issues pertaining to biosimilars.

Find an Activity

Find an Activity

Find an Activity

Choose from the criteria below to find an activity that fits you best.

HIDE SEARCH

Changing the Safety Paradigm on IV Medication Use: Recognizing the Risk and Taking Action

Activity Downloads

To Participate

To participate in this continuing education activity:

  1. Review the activity description and objectives.
  2. View the activity.
  3. Complete the online post-test and activity evaluation.

NOTE: If you attended the live CE activity titled "Changing the Safety Paradigm on IV Medication Use: Recognizing the Risk and Taking Action" that was held on March 31, 2017 during the AONE Annual Meeting in Baltimore, Maryland AND received CE credit (i.e. a nurse CE certificate), you are ineligible to also receive CE credit for this home-study activity.

Activity Description

Errors involving IV medications can result in significant patient harm, given the immediate bioavailability and narrow therapeutic index of many of the drugs used. This activity will address the multi-factorial risks associated with IV medications, along with the need for proven safety technologies, practice innovation, and educational strategies to enhance safety in all phases of the medication use process. Expert speakers will describe technologies available to support safe compounding and distribution practices with IV therapy, as well as the value of adopting barcoding technology and smart infusion pumps integrated with the electronic health record (EHR) to promote safe administration at the bedside.

Learning Objectives

The target audience for this activity includes nurses in health care settings. Upon completion of this activity, participants will be able to:

  • Describe the system-based causes of IV medication errors.
  • Identify the most common unsafe practices and at-risk behaviors associated with the preparation and administration of IV medications.
  • Discuss several technologies designed to support safe practice with IV medication use.
  • Recognize the role of nursing leadership in the adoption of technology and practice changes to enhance the safety of IV medication use.

Faculty

Moderator: Nicole Mollenkopf, PharmD, MBA, BCPS
Assistant Professor
Johns Hopkins School of Nursing
Baltimore, Maryland

Susan Paparella, MSN, RN
Vice President
Institute for Safe Medication Practices
Horsham, Pennsylvania

Michelle Mandrack, MSN, RN
Director of Consulting Services
Institute for Safe Medication Practices
Horsham, Pennsylvania

Disclosure

It is the policy of ProCE, Inc. to ensure balance, independence, objectivity and scientific rigor in all of its continuing education activities. Faculty must disclose to participants any significant financial interest or affiliation with companies that manufacture or market products discussed during their presentation. Dr. Mollenkopf, Ms. Paparella, and Ms. Mandrack have no relevant commercial or financial relationships to disclose.

Please note: The opinions expressed in this activity should not be construed as those of the CME/CE provider. The information and views are those of the faculty through clinical practice and knowledge of the professional literature. Portions of this activity may include unlabeled indications. Use of drugs and devices outside of labeling should be considered experimental and participants are advised to consult prescribing information and professional literature.

CE Accreditation

Release Date: 5-18-2017
Expiration Date: 5-18-2020

Nurses

This CE activity is jointly provided by the Institute for Safe Medication Practices (ISMP), ProCE, Inc., and Wild Iris Medical Education, Inc. This activity provides 1.0 contact hour of nurse CE credit.

Wild Iris Medical Education, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Funding

This CE activity is supported by an educational grant from BD.

 

The material presented in this CE activity does not reflect the views of ProCE, Inc. or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.